Mayo Clinic collaborated on a new treatment approach that combines two immunotherapies given before surgery for a common type of kidney cancer called clear cell renal cell carcinoma. The approach showed promising results in early-stage study #AACR26:
https://
abstractsonline.com/pp8/#!/21436/p
resentation/12011
…